Sirius Medical Expands Surgical Marker Navigation in the U.S.

07 Sep 2023
www.prnewswire.com
EINDHOVEN, NL, Sept. 7, 2023 /PRNewswire/ -- Sirius Medical, a leader in value-based healthcare and surgical marker navigation announced that LifeBridge Health, with locations across Maryland, will offer tumor localization with the Pintuition® surgical marker navigation system.
Continue Reading
Sirius Medical Expands Surgical Marker Navigation in the U.S.
Preview
Source: PRNewswire
Sirius Medical Expands in the U.S.
With many breast cancers being diagnosed at an early stage, the tumor often cannot be seen during surgery.  Pintuition is a next generation technology that is rapidly changing how tumors are localized.  The system use GPSDetect™ software providing unmatched directional guidance to locate tumors easily and accurately.  Patients benefit from enhanced diagnostic accuracy, reduced procedure times, and improved treatment planning.
"We are always searching for ways to create a better experience for our patients, adding new technology with surgical marker navigation to our breast cancer program further enhances our patient-centered care," says Dona Hobart, M.D., LifeBridge Health Medical Group.
"We are pleased to welcome LifeBridge Health to our expanding customer base in the U.S.," states Bram Schermers, CEO, Sirius Medical. "Physicians and administrators are embracing surgical marker navigation validating its simplicity, precision, and affordability."
For more information about Sirius Medical please visit www.sirius-medical.com
With its roots deeply embedded in the Netherlands Cancer InstituteCancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is precise, simple, affordable and both CE marked, and FDA cleared. Sirius Medical is rapidly expanding with over 14,000 procedures worldwide in over 175 centers combined with a global commercial network covering the USA, Western Europe and Australia-New Zealand.
Media Contact:
Benjamin Tchang - Corporate contact
[email protected]
+31 857 732 727 (The Netherlands)
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.